The Time is Now

Gene Network Sciences (GNS) is a privately held biotechnology firm at the leading edge of today's convergence of breakthroughs in genomics and supercomputing. We were founded in 2000 to put the power of modern mathematics and computation at the center of the drug discovery and development process.

Our company, which is headquartered in the biotechnology center of Cambridge, Massachusetts, is a uniquely collaborative team of computational physicists, mathematicians, chemists, molecular biologists, bioinformaticians, and software engineers. Through our own discovery efforts and in partnership with many leading innovator health care companies, we are building the future of medicine by revealing the molecular basis of health and disease through the critical biological relationships among genes and proteins, disease progression, and drug efficacy and toxicity. And we are doing this faster than ever thought possible.

We derive value from our technology through a combination of:

  • Collaborating with academic clinics to discover novel disease mechanisms, drug targets, and markers of disease
  • Partnering with biotechnology, pharmaceutical, and diagnostic companies to create new drugs and diagnostic tools from GNS-owned intellectual property
  • Offering pharmaceutical and biotech companies access to GNS technology on a service basis to advance their therapeutic candidates.

Case Studies
Supercomputers Massively-parallel supercomputers power GNS REFSTM technology
Cells Advanced data generation fuels REFSTM discoveries of disease mechanisms, drug targets, and biomarkers